Login
$ADCT
$1.25 +$0.00 (0.0%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Ameet Mallik Also a director
Chief Executive Officer
53 Since 2022
4 years
$2,453,150
Jose “Pepe” Carmona
Chief Financial Officer
Not stated Since 2022
4 years
$1,247,003
Peter Graham
Chief Legal Officer
Title from the Form 4 dated Jun 30, 2026
Not stated Not stated Not reported
Mohamed Zaki
Chief Medical Officer
Not stated Since 2023
3 years
$1,515,566

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
9
serving now
Independent
7 of 9
stated in the proxy
Average tenure
4.9 years
from year joined
CEO also chairs the board
No
Ron Squarer
Director Age On board Independent Committees Other public boards 2025 pay Source
Ron Squarer
59 2020
6 years
Not independent None stated Nuvalent Inc., Travere Therapeutics $249,197
Ameet Mallik
53 2022
4 years
Not independent None stated None stated Paid as CEO
Peter Hug
67 2019
7 years
Independent
Compensation Committee · Chair Nomination and Corporate Governance Committee
None stated $250,968
Robert Azelby
58 2023
3 years
Independent
Audit Committee Compensation Committee
Autolus Therapeutics, Cardinal Health, Terns Pharmaceuticals $211,100
Jean-Pierre Bizzari
71 2022
4 years
Independent
Nomination and Corporate Governance Committee · Chair Science and Technology Committee
APREA Therapeutics, Inc. $206,100
Timothy Coughlin
59 2025
1 year
Independent
Audit Committee · Chair
Travere Therapeutics, Inc., aTyr Pharma, Inc. $431,129
Viviane Monges
62 2021
5 years
Independent
Audit Committee Nomination and Corporate Governance Committee
BioMérieux SA, Pharvaris GmBH $246,414
Tyrell J. Rivers
53 2018
8 years
Independent
Science and Technology Committee
Cellectis S.A. Not stated
Victor Sandor
59 2020
6 years
Independent
Compensation Committee Science and Technology Committee · Chair
Kymera Therapeutics, Inc., Prelude Therapeutics Incorporated $211,100

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 20, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support